New drug gemini tested for kidney disease safety
Disease control
Completed
This completed study tested a single dose of the experimental drug Gemini in 40 adults with stage 3 or 4 chronic kidney disease. The main goal was to check safety and side effects compared to a placebo. Researchers also measured how the drug moves through the body and its effect …
Phase: PHASE1, PHASE2 • Sponsor: Revelation Biosciences, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC